Methylphenidate-associated chest pain in a child.
Child and adolescent psychiatry
Child and adolescent psychiatry (paediatrics)
Developmental paediatrics
Psychiatry (drugs and medicines)
Unwanted effects / adverse reactions
Journal
BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291
Informations de publication
Date de publication:
27 Nov 2023
27 Nov 2023
Historique:
pmc-release:
27
11
2025
medline:
29
11
2023
pubmed:
28
11
2023
entrez:
27
11
2023
Statut:
epublish
Résumé
A young child was diagnosed with autism spectrum disorder with comorbid attention-deficit/hyperactivity disorder. His hyperactivity, impulsivity and absence of awareness towards danger increased his risk of harm and hence methylphenidate was indicated. Unfortunately, he developed chest pain eight months after the treatment initiation. We then stopped the stimulant and changed his treatment to atomoxetine, after which he no longer had chest pain. In the following illustrated case, we will discuss the cardiac side effect of methylphenidate.
Identifiants
pubmed: 38011950
pii: 16/11/e255187
doi: 10.1136/bcr-2023-255187
pmc: PMC10685918
pii:
doi:
Substances chimiques
Methylphenidate
207ZZ9QZ49
Central Nervous System Stimulants
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.